Biotech Co. Says HHS Infringed Patent With Moderna Vax Deal
By Mark Payne · January 7, 2026, 7:13 PM EST
A biotech company that developed a patented protein technology that allegedly expedited the development of Moderna's COVID-19 Spikevax vaccine sued the U.S. Department of Health and Human Services on Wednesday, claiming...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login